Trials / Completed
CompletedNCT01251549
Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- ReWalk Robotics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
ReWalk suit developed by Argo Medical Technologies is designed to enable people with lower limb disabilities to carry out routine ambulatory functions (stand, walk etc.); it can be used by people with disabilities such as spinal cord injury, brain injury, stroke, multiple sclerosis, cerebral palsy and other pathologies that produce severe walking impairments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ReWalk - a motorized exoskeleton suit | The subject will wear the ReWalk suit and have training sessions for walking with the device |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2010-12-02
- Last updated
- 2016-10-05
Locations
2 sites across 2 countries: United States, Italy
Source: ClinicalTrials.gov record NCT01251549. Inclusion in this directory is not an endorsement.